Virginia E. Anello
Phone: 212-566-7500 x 233
New York Injury attorney Virginia E. Anello was born and raised in Covington, Louisiana. She attended Louisiana State University on an honors scholarship. Ms. Anello graduated from LSU magna cum laude and received a Bachelor of Science in Economics with a minor in Italian. She went on to attend the Paul M. Hebert Law Center at LSU where she received her Juris Doctor Degree and her Bachelor of Civil Law Degree, graduating in the top 30% of her class. Ms. Anello is admitted to practice law in the States of New York, Massachusetts and Louisiana. She is also admitted to practice law in the Eastern and Southern Districts of New York, the U.S. Court of Federal Claims in Washington, D.C. and the U.S. Court of Appeals for the Federal Circuit.
Since obtaining her law degree, Ms. Anello has devoted her entire career to always representing injury victims and consumers, primarily in mass tort and class actions. Her practice areas in the law have always focused on, and continue to focus on, products liability litigation and complex litigation, with an emphasis on consumer fraud and mass tort litigation. Consistent with the firm’s philosophy, she is dedicated to ensuring that an underdog can be heard.
Ms. Anello currently focuses her work on representing individuals nationwide who have been injured as a result of the defective diabetic drug Invokana, and she serves on the science, law and briefing and discovery committees in In Re: Invokana Products Liability Litigation (MDL-2750) pending in the United States District Court for the District of New Jersey before the Honorable Judge Brian Martinotti. In July 2017, Ms. Anello presented at Science Day before Judge Martinotti, defense counsel and other plaintiffs’ counsel from across the country about the current state of medical and scientific knowledge regarding Invokana, including how it works and how it causes the injuries alleged (diabetic ketoacidosis, acute kidney injury and amputations).
Ms. Anello is also active in many other nationwide pharmaceutical/medical device litigations, including those relating to hip replacement systems (DePuy ASR hip system, DePuy Pinnacle metal-on-metal hip system, Stryker Rejuvenate/ABGII modular hip stems and Stryker LFIT V40 femoral heads), proton pump inhibitors (Prilosec, Nexium, Prevacid, Protonix,) and the acid concentrate Granuflo. In addition, Ms. Anello works alongside firm partner, Michael A. London, in representing women who have been injured as a result of their in utero exposure to the drug Diethylstilbestrol (“DES”). Other products liability litigations which Ms. Anello has worked on through settlement include the Vioxx litigation, the Biomet M2A hip replacement system litigation, the Wright Conserve hip replacement system litigation, the Medtronic Sprint Fidelis Lead Wire litigation, and the Contaminated Heparin litigation.
While proud to represent individuals from across the country in the products liability arena, Ms. Anello is equally as proud to focus her legal efforts towards the New York City area. She is actively involved in representing individuals who have been injured as a result of their exposure to toxins at the World Trade Center site following September 11, 2001. She originally represented these victims in the World Trade Center Disaster Site Litigation pending before the Honorable Judge Alvin Hellerstein of the United States District Court for the Southern District of New York and she oversaw the firm’s settlement of that matter. Since Congress reopened the September 11, 2001 Victims’ Compensation Fund in 2010 and continued it in 2015, Ms. Anello has been directing her efforts at ensuring that these injured individuals, as well as those injured as a result of their working, living and going to school in the Lower Manhattan area, are compensated under the Act.
Additionally, as the spearhead of the firm’s class action litigation department, Ms. Anello represents New York residents who lost power due to the grossly negligent conduct of the Long Island Power Authority and its managing contractor, National Grid, prior to and following Superstorm Sandy. A proposed class action is currently pending in Nassau County Supreme Court before the Honorable Judge Antonio Brandveen.
As a class action attorney, Ms. Anello represents consumers and union health funds and other insurers who have been deceived and misled by product manufacturers. She is particularly involved in all of the firm’s class action work, including the firm’s class action against Bayer in which it was alleged that Bayer falsely represented to consumers that its over-the-counter combination aspirin drugs, Bayer Women’s Low Dose Aspirin + Calcium and Bayer with Heart Advantage delivered certain health benefits, which they, in fact, did not. Thanks to her hard work and dedication, as well as that of the firm, the Bayer combination aspirin class action settled for $15 million. Ms. Anello and Douglas & London are always investigating new class actions.
In addition to the above work, Ms. Anello oversees the firm’s vaccine litigation department. She has handled numerous cases in the program, many of which have settled or been successfully adjudicated on the merits. In this endeavor, she and her team at Douglas & London, P.C., represent children and adults who have been injured by vaccinations in the National Vaccine Injury Compensation Program.
Ms. Anello is an active member of the New York State Trial Lawyers Association (NYSTLA) and American Association of Justice (AAJ). Since 2014, Super Lawyers has selected Ms. Anello as a Rising Star in New York, and, in 2018, she was selected by Peer Recognition as one of Best Lawyers in New York City as published in the Wall Street Journal.
"Since the inception of the firm, Douglas & London has taken the opportunity to give back to the community. It is a right, a privilege and a responsibility our firm takes very seriously. We fully understand that without community, there’s no Douglas & London."-- The Team at Douglas & London